UK MP Adam Afriyie Wins Award for Advocacy of E-cigarettes in Parliament

Events by 2FIRSTS.ai
Nov.29.2023
UK MP Adam Afriyie Wins Award for Advocacy of E-cigarettes in Parliament
British MP Adam Afriyie won the "most supportive to Parliament" award at an e-cigarette industry event in Windsor, UK.

According to a report from UK media outlet inews on November 28, Member of Parliament Adam Afriyie won the "Most Supportive to Parliament" award at the annual awards ceremony hosted by the UK Vaping Industry Association (UKVIA) in early November. This award recognizes individuals who advocate for e-cigarettes in Parliament.

 

According to the UK Vaping Industry Association, Avrille warned in a speech that there is a global battle underway to elevate the position of the e-cigarette industry in smoking cessation solutions. Avrille expressed his gratitude to UKVIA for the awards they bestowed upon him and for their efforts in helping smokers quit their deadly addiction and save lives.

 

However, Averie did not disclose his wife's stake in the e-cigarette retailer.

 

In May, it was revealed by the media that Tracy-Jane Afriyie is the third-largest shareholder of Elite Growth, a global e-cigarette retailer. Elite Growth sells a disposable e-cigarette called Moodbar under the brand Nebulos.

 

According to recent news revelations, it has been disclosed that Mrs. Afuriye is now listed as a shareholder in the Nebulose-cigarette brand itself. This suggests that the Conservative MP's family has a direct interest in disposable e-cigarette matters.

 

Member of Parliament, Mr. Afriyie, has not publicly disclosed his wife's shares in Elite Growth and Nebulos. Furthermore, he has been advocating for the benefits of e-cigarettes as a smoking cessation tool since these shares were listed. Afriyie is among a group of politicians urging the government to adopt a more lenient approach towards e-cigarettes at the upcoming global tobacco control COP10 summit.

 

The meeting, which was attended by signatories of the Framework Convention on Tobacco Control from the UK and other countries, was postponed earlier this month due to regional violence.

 

During the period, minutes from a meeting of the All-Party Parliamentary Group (APPG) on Vaping displayed that Mr. Avery, the group's Vice Chairman, suggested that the British delegation attending the conference should propose a motion "highlighting the UK as a successful case in reducing tobacco harm" and opposing a ban on disposable e-cigarettes.

 

Afterwards, data released by the United Kingdom's National Health Service revealed that the nicotine content of disposable e-cigarettes is equivalent to that of 20 regular cigarettes. This has sparked a debate over the myth of e-cigarettes being relatively harmless. A spokesperson for Afriyie did not respond to accusations that he may have violated lobbying regulations, but told the media that he "will not comment on personal matters.

 

John Dunne, director of the UK E-cigarette Industry Association, has stated that the association, just like other trade associations in the UK, "advocates for the benefits this industry can bring to society.

 

However, Phil Chamberlain, Deputy Director of the Tobacco Control Research Group at the University of Bath, has called on Parliament to introduce a "better lobbying register and increase more transparency when documenting industry interactions." He stated, "The current regulations are too lenient and, as evidenced by the revelations in the 'Inquiry' newspaper, it is clear that the existing system has not been properly implemented.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Ispire and Jincheng Pharma Form Joint Venture to Enter Global High-Growth Nicotine Pouch Market
Ispire and Jincheng Pharma Form Joint Venture to Enter Global High-Growth Nicotine Pouch Market
Summary Ispire Technology announced a strategic joint venture with Chinese pharmaceutical company Jincheng Pharma to manufacture and commercialize nicotine pouch products. The partnership combines pharmaceutical-grade production capabilities with Ispire’s global regulatory infrastructure and distribution network as the company expands beyond vaping hardware into oral nicotine products.
Business
May.13
FDA 2025 NYTS: Youth E-Cigarette Use Declines but Unauthorized Disposables Remain Prominent; Nicotine Pouch Use Stays Low
FDA 2025 NYTS: Youth E-Cigarette Use Declines but Unauthorized Disposables Remain Prominent; Nicotine Pouch Use Stays Low
The U.S. Food and Drug Administration (FDA) released its 2025 National Youth Tobacco Survey analysis, saying about 2.01 million U.S. middle and high school students currently used any tobacco product; among current youth e-cigarette users, unauthorized disposable brands including Geek Bar, Elf Bar, Lost Mary and Raz had high reported shares, potentially making them a focus for future enforcement.
Jun.24
 BAT London Shares Gain 13.99% as FDA Vape Decision Draws Market Attention
BAT London Shares Gain 13.99% as FDA Vape Decision Draws Market Attention
British American Tobacco’s London-listed shares rose 13.99% last week, as investors focused on the U.S. Food and Drug Administration’s recent authorization of flavored Glas e-cigarette products, the dismissal of a U.S. sanctions-related criminal case against BAT, and the company’s previously announced share buyback plan and newer nicotine business performance.
BAT
May.18
Michael Olise’s World Cup Locker-Room Photo Puts Nicotine Pouches in the Sports Business Spotlight
Michael Olise’s World Cup Locker-Room Photo Puts Nicotine Pouches in the Sports Business Spotlight
Several European sports outlets have reported on a suspected nicotine pouch seen in French footballer Michael Olise’s locker photo, bringing football’s long-running “snus” culture back into public view and highlighting brand visibility, product classification and public-health debate around nicotine pouches in sports settings.
News
Jun.25 by 2Firsts Perspectives
Nicotine Pouches Lead U.S. Tobacco Growth as Vape Sales Decline
Nicotine Pouches Lead U.S. Tobacco Growth as Vape Sales Decline
New convenience store industry data show nicotine pouches have become the primary growth driver in the tobacco category, with oral nicotine sales rising nearly 30% over the past year while vape sales declined.
Business
Jun.05
Bloomberg: Zyn’s Dry-Mouth Problem Threatens Its Hold on Nicotine Pouch Market
Bloomberg: Zyn’s Dry-Mouth Problem Threatens Its Hold on Nicotine Pouch Market
According to Bloomberg, Philip Morris International’s Zyn is facing growing competition in the U.S. nicotine pouch market as consumers shift toward moister alternatives such as British American Tobacco’s Velo Plus.
BATPMI
May.22